A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
Weight loss drugs continue to make headlines. A new study conducted by researchers from the University of Southern ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
News Medical on MSN1d
Low-dose semaglutide reduces alcohol consumption and cravings in early trialResearch reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback